misonidazole has been researched along with Injuries, Radiation in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, M; Lv, B; Qiu, J; Wang, X; Zheng, X; Zhuo, W | 1 |
| Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J | 1 |
| Adams, GE; Jameson, DG | 1 |
| Arcangeli, G; de Pauw, M; De Vilhena, M; Horiot, JC; Schraub, S; Svoboda, V; Van den Bogaert, W; van der Schueren, E; Van Glabbeke, M | 1 |
| Hendry, JH; Sutton, ML | 1 |
| Curry, B; Feldstein, M; Fulton, DS; Hanson, J; Huyser-Wierenga, D; Johnson, ES; Mielke, B; Scott-Brown, I; Urtasun, RC | 1 |
1 review(s) available for misonidazole and Injuries, Radiation
| Article | Year |
|---|---|
Time effects in molecular radiation biology.
Topics: Animals; Bacillus megaterium; Cell Line; Cell Survival; Cells; Cricetinae; DNA; Free Radicals; Lung; Misonidazole; Oxygen; Pulse Radiolysis; Radiation Effects; Radiation Injuries; Radiation-Sensitizing Agents; Spectrometry, Fluorescence; Time Factors; Water | 1980 |
4 trial(s) available for misonidazole and Injuries, Radiation
| Article | Year |
|---|---|
Misonidazole combined with radiotherapy in the treatment of inoperable squamous cell carcinoma of the lung. A double-blind randomized trial.
Topics: Aged; Carcinoma, Squamous Cell; Double-Blind Method; Esophagitis; Humans; Lung Neoplasms; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Placebos; Pneumonia; Radiation Injuries; Radiotherapy Dosage; Random Allocation; Vomiting | 1983 |
The Medical Research Council trial of misonidazole in carcinoma of the uterine cervix. A report from the MRC Working Party on misonidazole for cancer of the cervix.
Topics: Adult; Aged; Brachytherapy; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Middle Aged; Misonidazole; Nitroimidazoles; Prognosis; Radiation Injuries; Radiotherapy Dosage; Uterine Cervical Neoplasms | 1984 |
The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects.
Topics: Female; Head and Neck Neoplasms; Humans; Male; Misonidazole; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy; Radiotherapy Dosage; Survival Rate | 1995 |
Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study.
Topics: Adolescent; Adult; Age Factors; Aged; Astrocytoma; Brain; Brain Neoplasms; Cobalt Radioisotopes; Combined Modality Therapy; Cranial Irradiation; Dose-Response Relationship, Radiation; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Misonidazole; Multivariate Analysis; Necrosis; Proportional Hazards Models; Radiation Injuries; Radioisotope Teletherapy; Radiotherapy Dosage; Severity of Illness Index; Skin Diseases; Survival Analysis; Survival Rate; Treatment Outcome | 1992 |
2 other study(ies) available for misonidazole and Injuries, Radiation
| Article | Year |
|---|---|
Topics: Adult; Carcinoma; Feasibility Studies; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Misonidazole; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Organs at Risk; Positron Emission Tomography Computed Tomography; Radiation Injuries; Radiation Tolerance; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Sampling Studies; Treatment Outcome; Tumor Burden | 2017 |
Care with radiosensitizers.
Topics: Animals; Misonidazole; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1978 |